BioSpace News Archive

Lycera Corp., a privately held biopharmaceutical company developing breakthrough immune modulatory medicines, today announced that two abstracts highlighting data from ongoing clinical studies of the company’s novel immuno-oncology therapeutic candidate, LYC-55716,

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today findings from a U.S. survey of more than 300 patients living with sleep apnea, and more than 300 partners of those with sleep apnea.

Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal 2019 financial results at 6:00 am EST on Tuesday, November 6, 2018.

Omnicell, Inc. (NASDAQ: OMCL) today announced that Augusta University Health (AU Health), based in Augusta, Ga., has selected Omnicell’s comprehensive, industry-leading medication management platform to help enhance financial performance

Reader Study Evaluating Concurrent-Read Interpretation of Screening Automated Breast Ultrasound (ABUS) Exams Published in American Journal of Radiology.

Data demonstrates safety and effectiveness of the Pure-Vu® System in patients who had minimal preparation regimens and who were allowed to consume solid food the day before the procedure

Pierre Fabre today announced it will join the Embleema Health Blockchain Consortium, which brings together patient advocacy groups, life sciences companies and healthcare providers inside a decentralized blockchain network where digital health data is shared by patients to monitor the safety and efficacy of new drugs in development.

Funding to support commercialization of ExoView™ system

Doctors at Qatar’s first specialist women’s and children’s hospital Sidra Medicine have successfully separated conjoined twins, marking a first for the country.

In-depth test results provide important information that can assist patients, caregivers and physicians in selecting the best prescription Rx’s for each individual.